Fig. 3.
The level of Hsp27 (a), Hsp72 (b), cytochrome c (c cytoplasmic, d mitochondrial fraction), beclin 1 (e), LC3 (f), Ras (g) and Raf (h) expression with representative blots and the activity of caspase 3, 8, 9 (i) after sorafenib (S) and quercetin (Q) treatment for 24 h in MOGGCCM. The data were normalised relative to β-actin (not shown). C control cells, SQ simultaneous drug treatment, * P < 0.05 compared to control